Boston Partners lifted its position in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 29.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,210,595 shares of the company's stock after acquiring an additional 736,567 shares during the quarter. Boston Partners owned approximately 0.24% of Keurig Dr Pepper worth $109,893,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. ST Germain D J Co. Inc. purchased a new stake in Keurig Dr Pepper during the first quarter valued at about $27,000. Continuum Advisory LLC grew its position in Keurig Dr Pepper by 82.5% during the first quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock valued at $46,000 after acquiring an additional 602 shares during the last quarter. Global Trust Asset Management LLC bought a new position in Keurig Dr Pepper during the first quarter valued at approximately $48,000. LRI Investments LLC grew its position in Keurig Dr Pepper by 65.6% during the fourth quarter. LRI Investments LLC now owns 1,527 shares of the company's stock valued at $49,000 after acquiring an additional 605 shares during the last quarter. Finally, Riverview Trust Co grew its holdings in shares of Keurig Dr Pepper by 47.7% in the first quarter. Riverview Trust Co now owns 1,710 shares of the company's stock worth $59,000 after purchasing an additional 552 shares during the last quarter. Institutional investors own 93.99% of the company's stock.
Analyst Ratings Changes
Several research analysts have recently issued reports on KDP shares. JPMorgan Chase & Co. cut their target price on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a report on Thursday, July 17th. UBS Group cut their target price on shares of Keurig Dr Pepper from $42.00 to $40.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Hsbc Global Res upgraded shares of Keurig Dr Pepper from a "hold" rating to a "strong-buy" rating in a report on Friday, April 25th. HSBC upgraded shares of Keurig Dr Pepper from a "hold" rating to a "buy" rating and lifted their price target for the company from $36.00 to $42.00 in a report on Friday, April 25th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and issued a $42.00 price target on shares of Keurig Dr Pepper in a report on Tuesday, April 22nd. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $39.77.
Check Out Our Latest Report on Keurig Dr Pepper
Insider Buying and Selling
In related news, Director Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $32.90, for a total value of $6,843,200.00. Following the completion of the sale, the director directly owned 2,292,169 shares in the company, valued at approximately $75,412,360.10. This trade represents a 8.32% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director De Ven Michael G. Van purchased 15,000 shares of the business's stock in a transaction on Wednesday, June 4th. The shares were purchased at an average price of $33.20 per share, with a total value of $498,000.00. Following the completion of the purchase, the director owned 15,000 shares in the company, valued at approximately $498,000. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 672,000 shares of company stock worth $22,235,760. 0.40% of the stock is owned by corporate insiders.
Keurig Dr Pepper Stock Up 0.4%
Keurig Dr Pepper stock traded up $0.15 on Friday, hitting $34.78. 6,246,850 shares of the stock traded hands, compared to its average volume of 9,794,757. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56. The firm has a market cap of $47.25 billion, a P/E ratio of 31.05, a price-to-earnings-growth ratio of 2.54 and a beta of 0.45. The business's fifty day simple moving average is $33.50 and its 200 day simple moving average is $33.54. Keurig Dr Pepper, Inc has a 1 year low of $30.12 and a 1 year high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.49. The firm had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%. Keurig Dr Pepper's quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.45 EPS. As a group, sell-side analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were issued a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 2.6%. The ex-dividend date was Friday, June 27th. Keurig Dr Pepper's dividend payout ratio (DPR) is presently 82.14%.
Keurig Dr Pepper Company Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Recommended Stories

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.